Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 30 Jun 22 EFFECT Notice of effectiveness
-
24 Jun 22 POS AM Prospectus update (post-effective amendment)
- 9 Apr 21 EFFECT Notice of effectiveness
- 6 Apr 21 POS AM Prospectus update (post-effective amendment)
- 28 Apr 20 EFFECT Notice of effectiveness
- 22 Apr 20 POS AM Prospectus update (post-effective amendment)
ADIL similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the inclusion in this Amendment No. 3 to Registration Statement on Form S-1 (File No. 333-229615) of our report dated March 28, 2022, with respect to our audits of the consolidated financial statements of Adial Pharmaceuticals, Inc. as of December 31, 2021 and 2020 and for each of the years in the two year period ended December 31, 2021. We also consent to the reference to our firm under the heading “Experts” in this Registration Statement.
/s/ Friedman LLP
Marlton, New Jersey
June 24, 2022